The ability of TFF1 to accelerate the differentiation of HPCs into BECs might be useful for treating patients with biliary-related dysfunctions, such as primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC). This evidence concerns the gene TFF1 and pancreatic serous cystadenoma.